Conducting research on BMP2 in OSCC may enable the development of precision-targeted therapeutic regimens targeting BMP2, which can effectively suppress the proliferation, invasion, and metastasis of cancer cells, thereby enhancing the therapeutic efficacy and improving the survival status of patients. Here, BMP2 is linked to cancer.